Helius Medical Technologies, Inc. (NASDAQ: HSDT) (“Helius” or the “Company”), a neurotech company focused on delivering a novel therapeutic neuromodulation approach for ...

Company previously granted extension until June 30, 2025 to regain compliance with Nasdaq’s Equity Rule requirementNEWTOWN, ...

A Breakthrough Botanical Formula Backed by 2025 Nobel Research Offers Lasting Relief from Ear Ringing and Auditory Imbalance ...

ASCO Annual Meeting is taking place in Chicago, US, from May 30 to June 3. Duality Bio (HKEX: 9606.HK) presented the ...

Investor capital is pouring into AI-driven healthcare, with Pittsburgh-based Abridge AI Inc. pulling in $300 million at a ...

Helius Medical Technologies ( ($HSDT) ) just unveiled an update. On June 3, 2025, Helius Medical Technologies received formal notification from ...

In today’s fast-paced and information-driven world, mental clarity is a precious commodity. Many people experience “brain fog ...

LivaNova submitted a request to the CMS to reconsider national coverage for its Vagus Nerve Stimulation (VNS) Therapy in ...

2025年6月4日， 波士顿科学（BSX）披露2笔公司内部人交易情况。高管Fitzgerald Joseph Michael于2025年6月4日买入5.64万股。